Non-invasive tests used to stage liver fibrosis in metabolic dysfunction-associated steatohepatitis play a growing role in care and trial recruitment, but their performance in routine practice may differ from results seen in clinical studies.
Non-invasive tests used to stage liver fibrosis in metabolic dysfunction-associated steatohepatitis play a growing role in care and trial recruitment, but their performance in routine practice may differ from results seen in clinical studies.
Trials are clean. Clinics are not. Show me the real-world numbers first.